Two recent studies have indicated that Testosterone Therapy may increase the risk of heart attacks and stroke in patients. The Journal of the American Medical Association (JAMA) published a study in late 2013 that reports they found the risk of heart attack and stroke increased almost 30% in patients that used Testosterone Therapy. The JAMA study was conducted on 8000 men and the heart attack and stroke rate was 30% higher in patients that were given Testosterone Therapy vs those that had not. Then in Feb. 2014 a study published in PLOS One stated that data found that men over 65 who took Testosterone Therapy double their risk of heart attack. Also, men who have a history of heart disease triple their risk of heart attack. The PLOS One study was conducted by the University of California by running tests on 56,000 males of a variety of ages. The FDA has stated based on these two studies that they are now actively researching these dangerous Testosterone Therapy side effects. Testosterone Therapy is sold under brand names such as: AndroGel, Axiron, Fortesta, Striant, and Testrim. It's not known how the FDA will ultimately respond to these studies, but a Testosterone Therapy FDA recall could result in massive filings of lawsuits against the manufacturers.
"Low T" is caused by Hypogonadism and is identified by a blood test first thing in the morning as Testosterone levels drop in men during the day. "Low T" or Low Testosterone isn't a recognized medical issue until the levels of Testosterone become very, very low caused by hypogonadism or hormonal deficiencies. Testosterone Treatments or Testosterone Therapy are usually prescribed when total Testosterone levels fall below 300–1000 ng/dL. It is also one the most advertised pharmaceutical products in the United States. Androgel marketing alone cost around $80 million dollars last year. The Testosterone Therapy industry generated $2 billion dollars in sales in 2013. According to the Journal of the American Medical Association the use of Testosterone Therapy products increased by nearly 360% between 2001 and 2011 in men over the age of 40. There has been critics in the media that Testosterone Therapy treatments have been over prescribed. Other critics claim that Low T is over marketed and drops in Testosterone are simple result of men aging.
It has been reported that Testosterone Therapy have already been filed in IL by men claiming to have suffered heart attacks due to Testosterone Therapy or Low T treatments. If you or a loved one were taking Testosterone Therapy products and suffered a side effect such as a heart attack or stroke, you may be entitled to compensation. BCA's pharmaceutical attorneys have represented thousands of clients against some of the largest drug manufacturers in the world, including GlaxoSmithKline, Merck, Pfizer, and Bayer. BCA has a team of qualified and diverse group of in-house and of-counsel attorneys all over the United States. Complete the contact us form and a Testosterone Therapy Claim Specialist will review your information and contact you about your Testosterone Therapy Claim. Or to speak to a Testosterone litigation specialist call us right now at: 855-435-5839.
Testosterone Litigation specialist are standing by now to answer you questions on Low T Lawsuits.
Or complete the Testosterone Free Case Evaluation below. Our attorneys will review your information and advise you on the best steps to ensure a maximum recovery.
* Indicates the Information is Required
BCA has created this section of our website to acknowledge the tremendous effort on behalf of our attorneys and employees in support of national and local charities. Click for BCA Charities >